Is GTXI a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

653 people get GTXI articles and Market Currents by email alert.

Get email alerts on GTXI »

HEADLINES:

PSivida Corporation And GTx: 2 Of The Most Undervalued Biotechs For 2013
Bob's Stocks • Mon, May 20 • 4 Comments
Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy
Scott Matusow • Tue, May 7 • 8 Comments
GTx Inc.'s CEO Discusses Q1 2013 Results - Earnings Call Transcript
Fri, May 3
GTx Provides Corporate Update and Reports First Quarter 2013 Financial Results

Business Wire (May 3, 2013)
GTx Initiating Phase 2, Open-Label Study of Enobosarm to Treat ER Positive Metastatic Breast Cancer

Business Wire (Apr 30, 2013)
GTx, Inc.: Is This Micro Cap Breaking Out?
Cora Schlesinger • Thu, Apr 25 • 21 Comments
GTx, Inc. To Host First Quarter 2013 Financial Results Conference Call and Webcast

Business Wire (Apr 19, 2013)
GTx And Trius Therapeutics: 2 Top Biotech Buys For 2013
Bob's Stocks • Wed, Apr 17 • 4 Comments
GTx's Phase III Clinical Studies of Enobosarm (GTx-024) to Continue as Planned Following Planned Safety Review

Business Wire (Apr 15, 2013)
Will 2013 Be A Big Year For GTx?
C.R. Jackson • Thu, Apr 11 • 9 Comments
GTx-758 Poster Presentation of Phase II Trial Data in Advanced Prostate Cancer Selected as One of the Best Posters at the 28th Annual European Association of Urology Congress

Business Wire (Mar 19, 2013)
Enobosarm Phase 2 Trial for Muscle Wasting and Physical Function in Patients with Cancer Published in The Lancet Oncology

Business Wire (Mar 14, 2013)
GTx Announces Webcast of Corporate Presentation at Cowen and Company 33rd Annual Health Care Conference

Business Wire (Feb 27, 2013)
GTx's Management Presents at Citi Global Healthcare Conference (Transcript)
Mon, Feb 25
GTx's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Feb 21 • 1 Comment
GTx Provides Corporate Update and Reports 2012 Financial Results

Business Wire (Feb 21, 2013)
GTx Announces Webcast of Corporate Presentation at 2013 Citi Global Healthcare Conference

Business Wire (Feb 19, 2013)
GTx's CEO Hosts Analyst Day Conference (Transcript)
Fri, Feb 15 • 1 Comment
GTx To Present Preclinical Data on a New Therapeutic Target in Prostate Cancer

Business Wire (Feb 14, 2013)
Novel Findings from Clinical Studies Examining the Effects of Capesaris® (GTx-758) for the Treatment of Advanced Prostate Cancer to be Presented at 2013 American Society of Clinical Oncology Genitourinary Cancer Symposium

Business Wire (Feb 13, 2013)

To learn more about Seeking Alpha Pro, click here.

Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy
Scott Matusow • Tue, May 7 • 8 Comments
GTx, Inc.: Is This Micro Cap Breaking Out?
Cora Schlesinger • Thu, Apr 25 • 21 Comments
GTx And Trius Therapeutics: 2 Top Biotech Buys For 2013
Bob's Stocks • Wed, Apr 17 • 4 Comments
Will 2013 Be A Big Year For GTx?
C.R. Jackson • Thu, Apr 11 • 9 Comments
Bullish Catalysts Make GTx Top Biotech Buy For Q1 2013
Natty Greene • Tue, Jan 8 • 19 Comments
Analyzing GTx, Inc.'s Vast Upside Potential
Natty Greene • Mon, Mar 26, 2012 • 9 Comments
If GTX Can Finally Catch A Break, The Rewards Look Worthwhile
Stephen Simpson • Thu, Mar 15, 2012 • 1 Comment
GTx Roaring Into Earnings: Potential Short-Term Momentum Play
Kinetic Investments • Tue, May 3, 2011 • 4 Comments
GTx Has to Reevaluate Options Following Prostate Cancer Drug Failure
EP Vantage • Thu, May 27, 2010
GTx, Inc.: A Diamond in a Mud Pit
Andrew Snyder • Thu, Apr 3, 2008 • 2 Comments
Does GTx Have the Muscle for Growth?
Anthony Payne • Thu, Feb 22, 2007

PSivida Corporation And GTx: 2 Of The Most Undervalued Biotechs For 2013
Bob's Stocks • Mon, May 20 • 4 Comments
Insider Buying Trends: Are These Cash-Rich Companies Ready For A Rally?
Kapitall • Tue, Sep 18, 2012 • 6 Comments
6 Cash-Heavy Biotech Stocks With Analyst Endorsements
ZetaKap • Thu, Aug 23, 2012
5 Pharmaceutical Companies With Phase III Clinical Study Catalysts During The Next 4 - 12 Months
Markus Aarnio • Tue, Aug 21, 2012 • 8 Comments
6 Biotech Stocks That Analysts Give The Green Light
ZetaKap • Fri, Jul 27, 2012
3 Rallying Stocks Under $5 Being Bought Up By Company Insiders
Kapitall • Sun, Jul 22, 2012 • 7 Comments
Lose-Lose Bets With Arena's FDA Approval
Gutone • Wed, Jun 27, 2012 • 37 Comments
Thursday's Bio-Pharma Drug Approval And Catalyst Event List
Scott Matusow • Thu, May 3, 2012 • 5 Comments
12 Healthcare Companies Expecting May Catalysts
Spencer Knight • Tue, May 1, 2012 • 9 Comments
Wednesday, April 18th Bio-Pharma Mover Watch List
Scott Matusow • Wed, Apr 18, 2012 • 9 Comments
Analyzing Tuesday's Noteworthy Insider Trades
GuruFundPicks • Wed, Apr 11, 2012 • 3 Comments
ArQule Dips, But Not Necessarily A Bargain
Stephen Simpson • Tue, Apr 10, 2012 • 2 Comments
Bio-Pharma Catalyst Trades That Offer Decent Short-Term Gains
Scott Matusow • Mon, Apr 9, 2012 • 5 Comments
Insider Buys And Sells: Corning, Cabela's
Asif Suria • Mon, Mar 12, 2012
Early Innovations In The Breast Cancer Therapeutic Market
Andrew J. Norris • Tue, Mar 6, 2012 • 13 Comments
Last Week's Noteworthy Institutional 5% Ownership Filings
GuruFundPicks • Mon, Mar 5, 2012 • 1 Comment
12 Highly Shorted Biotech Stocks Being Snapped Up By Insiders
Kapitall • Wed, Feb 15, 2012 • 1 Comment
14 Rallying Biotech Stocks Being Snapped Up By Insiders
Kapitall • Thu, Feb 2, 2012 • 1 Comment
VIX - Options Volatility Sonar: Monday Recap
Erick McKitterick • Mon, Jan 30, 2012
Best Performing Stocks Year To Date
Bespoke Investment Group • Mon, Jan 30, 2012 • 2 Comments

GTx Inc.'s CEO Discusses Q1 2013 Results - Earnings Call Transcript
Fri, May 3
GTx's Management Presents at Citi Global Healthcare Conference (Transcript)
Mon, Feb 25
GTx's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Feb 21 • 1 Comment
GTx's CEO Hosts Analyst Day Conference (Transcript)
Fri, Feb 15 • 1 Comment
GTX's CEO Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Transcript)
Tue, Nov 13, 2012 • 1 Comment
GTx Incorporated's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Thu, Nov 8, 2012
GTx's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Wed, Aug 8, 2012 • 1 Comment
GTx Inc Q4 2008 Earnings Call Transcript
Tue, Feb 17, 2009
GTx, Inc. Q3 2008 Earnings Call Transcript
Wed, Nov 19, 2008
GTx, Inc. Q2 2008 Earnings Call Transcript
Mon, Sep 8, 2008
GTx Inc. Q1 2008 Earnings Call Transcript
Mon, May 12, 2008
GTx Q4 2007 Earnings Call Transcript
Tue, Feb 19, 2008

GTx Provides Corporate Update and Reports First Quarter 2013 Financial Results

Business Wire (May 3, 2013)
GTx Initiating Phase 2, Open-Label Study of Enobosarm to Treat ER Positive Metastatic Breast Cancer

Business Wire (Apr 30, 2013)
GTx, Inc. To Host First Quarter 2013 Financial Results Conference Call and Webcast

Business Wire (Apr 19, 2013)
GTx's Phase III Clinical Studies of Enobosarm (GTx-024) to Continue as Planned Following Planned Safety Review

Business Wire (Apr 15, 2013)
GTx-758 Poster Presentation of Phase II Trial Data in Advanced Prostate Cancer Selected as One of the Best Posters at the 28th Annual European Association of Urology Congress

Business Wire (Mar 19, 2013)
Enobosarm Phase 2 Trial for Muscle Wasting and Physical Function in Patients with Cancer Published in The Lancet Oncology

Business Wire (Mar 14, 2013)
GTx Announces Webcast of Corporate Presentation at Cowen and Company 33rd Annual Health Care Conference

Business Wire (Feb 27, 2013)
GTx Provides Corporate Update and Reports 2012 Financial Results

Business Wire (Feb 21, 2013)
GTx Announces Webcast of Corporate Presentation at 2013 Citi Global Healthcare Conference

Business Wire (Feb 19, 2013)
GTx To Present Preclinical Data on a New Therapeutic Target in Prostate Cancer

Business Wire (Feb 14, 2013)
Novel Findings from Clinical Studies Examining the Effects of Capesaris® (GTx-758) for the Treatment of Advanced Prostate Cancer to be Presented at 2013 American Society of Clinical Oncology Genitourinary Cancer Symposium

Business Wire (Feb 13, 2013)
GTx Announces Webcast for Capesaris®(GTx-758) Analyst Day

Business Wire (Feb 12, 2013)
GTx, Inc. to Host Fourth Quarter and Full Year 2012 Financial Results Conference Call and Webcast

Business Wire (Feb 7, 2013)
GTx Announces Webcast of Corporate Presentation at Bio CEO & Investor Conference

Business Wire (Feb 5, 2013)
GTx Announces FDA’s Grant of Fast Track Designation to Enobosarm For the Prevention and Treatment of Muscle Wasting in patients with Non-Small Cell Lung Cancer

Business Wire (Jan 8, 2013)
GTx Attains Enrollment Goal for its Enobosarm POWER 1 and POWER 2 Phase III Clinical Studies

Business Wire (Dec 17, 2012)
GTx Provides Corporate Update and Reports Third Quarter 2012 Financial Results

Business Wire (Nov 8, 2012)
GTx Announces Webcast of Corporate Presentation at Jefferies 2012 Global Healthcare Conference

Business Wire (Nov 8, 2012)
GTx Announces Webcast of Corporate Presentation at Lazard Capital Markets 9th Annual Healthcare Conference

Business Wire (Nov 6, 2012)
GTx's Phase III Clinical Development of Enobosarm (GTx-024) for muscle wasting in lung cancer patients on Course Following Planned Safety Review

Business Wire (Oct 29, 2012)

GTXI vs. ETF Alternatives

Company Description

GTx, Inc., a Delaware corporation incorporated on September 24, 1997, is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other... More

Sector: Healthcare

Industry: Biotechnology

Country: United States

Scott Matusow
Added some $GTXI today, think it's headed over $6 soon
May 6, 3:58 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
6 Cash-Heavy Biotech Stocks With Analyst Endorsements http://bit.ly/TXLKnB $CYTX $PLX $GTXI $HALO $ILMN $THRX @ZetaKap
8/23/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

ZetaKap
6 Biotech Stocks That Analysts Give The Green Light http://bit.ly/MOcxzl $GTXI $ITMN $ILMN $QLTI $SGEN $VVUS @ZetaKap
7/27/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

reachmygoals1
GTXI is a hidden gem. waiting for the fda to resume phase ii for prostate cancer by may 4. any news of phase iii for ostarine catalyst spark
5/3/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

crookedneck
GTXI looks very good!
3/27/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

crookedneck
GTXI should break $5 short term and longer term could bring $8.00 or more imo! Buyout candidate too! Cheers!
3/27/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Todd Theman
Taking some of my earnings on GALE from last week and jumping in to GTXI.
3/26/12
Reply (1)

• !Report Abuse
View all 1 replies
crookedneck: I loaded on GTXI yesterday and the upside potential is huge! Cheers!
3/27/12
• !Report Abuse
Add a reply...

140 characters

Ryan Mallory
1/31 Video Watchlist GTXI SBSA BORN COCO LCC ZLC END FBN RNWK BIOL RPTP SIMO CDY bit.ly/yYz5od
1/31/12
Reply (2)

• !Report Abuse
View all 2 replies
Luckydad: link not working, try again.
1/31/12
• !Report Abuse
Ryan Mallory: Sorry about that - try this: http://bit.ly/A1U1WL
2/1/12
• !Report Abuse
Add a reply...

140 characters

Perkins Cove
GTXI up 20% pre market on strong volume, PT raised to $19. at Citigroup.
1/30/12
Reply (2)

• !Report Abuse
View all 2 replies
DianeLee: special attn to takeover "potential"
1/30/12
• !Report Abuse
Henry JXF: my god
1/30/12
• !Report Abuse
Add a reply...

140 characters

Ryan Mallory
High Flying Breakout Plays for Today: GLUU TSYS SPF GTXI INWK http://stk.ly/qtAPb6
7/13/11
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Todd Theman
Taking some of my earnings on GALE from last week and jumping in to GTXI.
3/26/12
Reply (1)

• !Report Abuse
View all 1 replies
crookedneck: I loaded on GTXI yesterday and the upside potential is huge! Cheers!
3/27/12
• !Report Abuse
Add a reply...

140 characters

Ryan Mallory
1/31 Video Watchlist GTXI SBSA BORN COCO LCC ZLC END FBN RNWK BIOL RPTP SIMO CDY bit.ly/yYz5od
1/31/12
Reply (2)

• !Report Abuse
View all 2 replies
Luckydad: link not working, try again.
1/31/12
• !Report Abuse
Ryan Mallory: Sorry about that - try this: http://bit.ly/A1U1WL
2/1/12
• !Report Abuse
Add a reply...

140 characters

Perkins Cove
GTXI up 20% pre market on strong volume, PT raised to $19. at Citigroup.
1/30/12
Reply (2)

• !Report Abuse
View all 2 replies
DianeLee: special attn to takeover "potential"
1/30/12
• !Report Abuse
Henry JXF: my god
1/30/12
• !Report Abuse
Add a reply...

140 characters

GTXI GTx, Inc.

GTXI

GTx, Inc.